---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-072876"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T04:00:07.440702+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Sciences believes it regained Nasdaq minimum equity compliance after $10.8M offering

## Summary
- Received Nasdaq deficiency notice May 16, 2024 for stockholders' equity of -$175,385 vs. $2.5M minimum requirement.
- Closed public offering May 29, 2024, raising approximately $10.8M in net proceeds from common stock and warrants.
- Company now believes it meets Nasdaq Listing Rule 5550(b)(1) stockholders' equity requirement.
- Nasdaq will continue monitoring; non-compliance at next periodic report may lead to delisting.

## SEC filing metadata
- accession: 0001104659-24-072876
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465924072876/0001104659-24-072876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465924072876/tm2417556d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-072876
- JSON: https://secwatch.observer/filing/0001104659-24-072876.json
- Plain text: https://secwatch.observer/filing/0001104659-24-072876.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.